BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31519559)

  • 41. Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.
    Alhenc-Gelas M; Plu-Bureau G; Hugon-Rodin J; Picard V; Horellou MH;
    Thromb Haemost; 2017 Jun; 117(6):1040-1051. PubMed ID: 28300866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulants in thrombosis and cancer: the missing link.
    Mousa SA
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):227-33. PubMed ID: 12113244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombotic risk factors: basic pathophysiology.
    Martinelli I; Bucciarelli P; Mannucci PM
    Crit Care Med; 2010 Feb; 38(2 Suppl):S3-9. PubMed ID: 20083911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk and Prognosis of Cancer After Lower Limb Arterial Thrombosis.
    Sundbøll J; Veres K; Horváth-Puhó E; Adelborg K; Sørensen HT
    Circulation; 2018 Aug; 138(7):669-677. PubMed ID: 29540440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.
    Hassan SA; Palaskas N; Kim P; Iliescu C; Lopez-Mattei J; Mouhayar E; Mougdil R; Thompson K; Banchs J; Yusuf SW
    Curr Atheroscler Rep; 2018 Feb; 20(2):10. PubMed ID: 29423705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venous and arterial thrombosis in dialysis patients.
    Ocak G; Vossen CY; Rotmans JI; Lijfering WM; Rosendaal FR; Parlevliet KJ; Krediet RT; Boeschoten EW; Dekker FW; Verduijn M
    Thromb Haemost; 2011 Dec; 106(6):1046-52. PubMed ID: 22012181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of anti-thrombotic agents during chemotherapy for epithelial ovarian cancer.
    Salman MC; Ayhan A
    Med Hypotheses; 2006; 66(6):1179-81. PubMed ID: 16446052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are direct acting oral anticoagulants ready for prime-time use in cancer-related thrombosis?
    Streiff MB
    Clin Adv Hematol Oncol; 2018 Mar; 16(3):180-184. PubMed ID: 29742073
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
    Mousa SA; Petersen LJ
    Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelets and cancer-associated thrombosis.
    Connolly GC; Phipps RP; Francis CW
    Semin Oncol; 2014 Jun; 41(3):302-10. PubMed ID: 25023346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors).
    Castaman G
    Thromb Res; 2016 Apr; 140 Suppl 1():S89-92. PubMed ID: 27067986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of infertility in male survivors of childhood cancer.
    Brannigan RE
    Lancet Oncol; 2014 Oct; 15(11):1181-2. PubMed ID: 25239574
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acute arterial thrombosis in a context of hyperhomocysteinemia: Case report and literature review].
    Raybaud G; Lambert M; Douillard C; Dessein AF; Morell-Dubois S; Guillou M; Haulon S; Hatron PY
    Rev Med Interne; 2016 Dec; 37(12):849-853. PubMed ID: 27842952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms and future directions for angiogenesis-based cancer therapies.
    Scappaticci FA
    J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of venous thrombosis in children with cancer.
    Piovesan D; Attard C; Monagle P; Ignjatovic V
    Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboprophylaxis in the cancer patient.
    Kakkar AK; Williamson RC
    Haemostasis; 1998; 28 Suppl 3():61-5. PubMed ID: 10069763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
    Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
    Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.
    Wun T; Law L; Harvey D; Sieracki B; Scudder SA; Ryu JK
    Cancer; 2003 Oct; 98(7):1514-20. PubMed ID: 14508840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
    Sallah S; Wan JY; Nguyen NP
    Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
    Revel-Vilk S; Yacobovich J; Tamary H; Goldstein G; Nemet S; Weintraub M; Paltiel O; Kenet G
    Cancer; 2010 Sep; 116(17):4197-205. PubMed ID: 20533566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.